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Zinc is a transition metal that has a long history of use as an anti-inflammatory agent. It also soothes pain sensations in a number of
animal models. However, the effects and mechanisms of zinc on chemotherapy-induced peripheral neuropathy remain unknown. Here
we show that locally injected zincmarkedly reducesneuropathic pain inmale and femalemice inducedbypaclitaxel, a chemotherapydrug, in a
TRPV1-dependentmanner.Extracellularlyappliedzincalso inhibits thefunctionofTRPV1expressedinHEK293cellsandmouseDRGneurons,
whichrequiresthepresenceofzinc-permeableTRPA1tomediateentryofzincintothecytoplasm.Moreover,TRPA1isrequiredforzinc-induced
inhibition of TRPV1-mediated acute nociception. Unexpectedly, zinc transporters, but not TRPA1, are required for zinc-induced inhibition of
TRPV1-dependent chronic neuropathic pain produced by paclitaxel. Together, our study demonstrates a novel mechanism underlying the
analgesic effect of zinc on paclitaxel-induced neuropathic pain that relies on the function of TRPV1.
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Introduction
Chemotherapy-induced peripheral neuropathy (CIPN), a highly
debilitating symptom without effective treatment, affects50%
of patients undergoing treatment with commonly used chemo-
therapy drugs, including paclitaxel, vincristine, and oxaliplatin
(Addington and Freimer, 2016). The painful neuropathy usually
leads to dose reduction or discontinuation of the treatment, re-
sulting in poor treatment outcomes. Currently, how chemother-
apies with certain drugs cause pain and neuropathy is not well
understood, which has severely limited the development of effec-
tive pain therapies (Hershman et al., 2014; Miltenburg and Boog-
erd, 2014). Therefore, it is critical to understand the molecular
and cellular mechanisms underlying the pathogenesis of CIPN to
develop effective and safe therapeutics for the treatment of CIPN.
Pain results from complex processing of neural signals at dif-
ferent levels. Transient receptor potential (TRP) channels are
molecular sensors for noxious mechanical, chemical, and ther-
mal insults. Activation of peripheral nociceptors by TRP chan-
nels, especially the capsaicin receptor TRPV1 and wasabi receptor
TRPA1, initiates neurogenic inflammation and pain sensation
(Caterina et al., 2000; Lee et al., 2005; Bautista et al., 2006; Huang
et al., 2008). TRPV1 is expressed in nearly 60% of peptidergic
small-diameter primary nociceptors in the dorsal root ganglia
(DRG) and trigeminal ganglia, which sense environmental cues
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Significance Statement
The chemotherapy-induced peripheral neuropathy is a major limiting factor affecting the chemotherapy patients. There is no
effective treatment available currently. We demonstrate that zinc prevents paclitaxel-induced mechanical hypersensitivity via
inhibiting the TRPV1 channel, which is involved in the sensitization of peripheral nociceptors in chemotherapy. Zinc transporters
in DRG neurons are required for the entry of zinc into the intracellular side, where it inhibits TRPV1. Our study provides insight
into the mechanism underlying the pain-soothing effect of zinc and suggests that zinc could be developed to therapeutics for the
treatment of chemotherapy-induced peripheral neuropathy.
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in the skin and many visceral organs (Xu et al., 2013). TRPV1 is a
nonselective cation channel that is activated by capsaicin, nox-
ious heat, acid, and many endogenous ligands as well as plant-
derived natural compounds. In addition to direct activation,
TRPV1 is also sensitized by activation of GPCRs and tyrosine
kinase receptors through intracellular signal transduction path-
ways involving activation of many protein kinases, including
protein kinase C (PKC), protein kinase A (PKA), and phospho-
inositide 3-kinase (PI3K). Both activation and sensitization of
TRPV1 lead to enhanced pain responses. Both genetic ablation
and pharmacological inhibition studies have provided convinc-
ing evidence that TRPV1 significantly contributes to both
chronic inflammatory pain and neuropathic pain resulting from
peripheral nerve injury. Moreover, both TRPV1 and TRPA1 have
been shown to be involved in the pathogenesis of CIPN (Boyette-
Davis et al., 2015).
Zinc is an essential metal that has been extensively used to
promote wound healing in humans for almost 3000 years (Lans-
down et al., 2007). It acts as an anti-inflammatory agent and soothes
pain sensation in a number of model systems (Safieh-Garabedian et
al., 1996; Larson and Kitto, 1999; Liu et al., 1999; Nozaki et al.,
2011). Zinc is present in the spinal cord and DRG neurons, in-
cluding small-diameter nociceptive neurons (Vela´zquez et al.,
1999; Koeppen et al., 2013). Indeed, depletion of vesicular zinc in
the spinal cord dorsal horn enhances neuropathic pain in mice (Jo et
al., 2008). Moreover, zinc-deficient mice have increased prosta-
glandin E2 levels and sensitized nociceptive C fibers, suggesting
that endogenous zinc might exert a tonic inhibition on nociception
(Izumi et al., 1995). Furthermore, centrally applied zinc attenuates
neuropathic pain in mouse models of peripheral neuropathy (Liu et
al., 1999; Nozaki et al., 2011) and clinical studies (Pastorfide et al.,
1989; Zekavat et al., 2015). However, it is not known whether exog-
enously applied zinc in the periphery can affect CIPN.
In the present study, we show that local application of zinc
inhibits mechanical hypersensitivity induced by paclitaxel treat-
ment in mice in a dose-dependent manner. The zinc-induced
analgesic effect is severely attenuated in TRPV1-deficient mice.
Extracellular zinc application inhibits capsaicin-evoked intracel-
lular calcium ([Ca 2]i) responses and membrane depolarization
in a subset of mouse DRG neurons, and locally injected zinc
inhibits capsaicin-evoked acute nociceptive behaviors. More-
over, zinc inhibits capsaicin-induced [Ca 2]i responses and
membrane current intracellularly, and the zinc-sensitive TRPA1
is required for the inhibition of TRPV1 by extracellular zinc.
Surprisingly, zinc transporters, but not TRPA1, are required for
inhibition of paclitaxel-induced chronic neuropathic pain by
zinc. Together, our data demonstrate that TRPV1-mediated pain
sensations are inhibited by extracellular zinc entering the cells
through either TRPA1 channels or zinc transporters under acute
and chronic settings.
Materials andMethods
Animals. Male and female C57BL/6J mice (The Jackson Laboratory),
congenic TRPV1 knock-out (KO) (The Jackson Laboratory), and con-
genic TRPA1 KO mice at the age of 7–10 weeks were used in this study.
The TRPA1 KO mice on the C57BL/6J background were described pre-
viously (Cruz-Orengo et al., 2008). All animal care and experimental
procedures were in accordance with the animal care and use protocol
approved by the Institutional Animal Care and Use Committee of Uni-
versity of Texas Health Science Center at Houston and the Institutional
Animal Care and Use Committee at Washington University School of
Medicine in St. Louis. All studies involving animals are reported in ac-
cordance with the ARRIVE guidelines for reporting experiments involv-
ing animals (McGrath et al., 2010). Mice were housed in a temperature
(24°C)- and humidity (40%–50%)-controlled environment on a 12:12 h
dark-light cycle with free access to food and water. All experiments were
performed blind with respect to genotypes and treatments.
Paclitaxel treatment and von Frey test. Paclictaxel (TSZ Chem) was
administered at a dose of 4 mg/kg intraperitoneally on days 0, 2, 4, and 6
as illustrated in Figure 1A according to previous studies (Matsumoto et
al., 2006). Mechanical allodynia was measured as the hindpaw with-
drawal response to von Frey hair stimulation using the up-and-down
method as described in our previous study (Yin et al., 2013). Intraplantar
injection of zinc acetate (ZnAc) (Sigma-Aldrich) was performed on day 7
following the von Frey test.
Intrathecal delivery of siRNA. To knockdown the ZIP family of zinc
transporters (ZIPs), the siRNAs specific for mZIP3, mZIP6, and mZIP7
and the siRNA Universal Negative Control were purchased from Sigma-
Aldrich, and 0.5 nmol of each was prepared in PBS and mixed with
polyethylenimine. After 15 min incubation at room temperature, the
mixture was injected intrathecally into mice anesthetized with isoflurane.
Animals were used 3 d after the final intrathecal injection.
Cell culture and transfection. HEK293 cells were obtained from ATCC
in 2010 and have been tested to confirm lack of mycoplasma contamina-
tion; however, no additional authentication has been performed. Cells
were grown as a monolayer using passage numbers30 and maintained
in DMEM (Invitrogen), supplemented with 10% FBS (Invitrogen), 100
units/ml penicillin and 100 g/ml streptomycin in a humidified incu-
bator at 37°C with 5% CO2. The cells were transiently transfected with
complementary DNA for mouse TRPV1 (mTRPV1), human TRPA1
(hTRPA1), and hTRPA1-D915A mutant using Lipofectamine 2000 (In-
vitrogen) with a ratio of 0.3:1. After transfection, cells were maintained in
DMEM at 37°C for 24 h before use. The hRPA1-D915A mutant was made
using the QuikChange II XL mutagenesis kit (Agilent Technologies),
according to the manufacturer’s directions and confirmed by DNA
sequencing.
Retrograde labeling of paw-innervating DRG neurons. Mice were anes-
thetized with isoflurane, and 10 l of 1,1-dilinoleyl-3,3,3,3-tetramethy-
lindocarbocyanine, 4-chlorobenzenesulfonate (FAST DiI) (10 mg/ml in
methanol) was injected into the paws of paclitaxel-treated mice. To pre-
vent leakage and labeling of adjacent tissues, the needle was left in place
for 30 s after each injection, and any leaked dye was removed with a
cotton swab. DRG neurons were isolated 5 d after DiI injection.
Isolation and culture of DRG neurons. Mice were killed by cervical
dislocation following CO2 asphyxia. Spinal columns were removed and
placed in ice-cold HBSS; neurons were acutely dissociated and main-
tained as described previously (Hu et al., 2009). In brief, laminectomies
were performed and bilateral DRG or lumbar DRG of DiI-injection side
were dissected out. After removal of connective tissues, DRG were trans-
ferred to a 1 ml Ca 2/Mg 2-free HBSS containing 2 l saturated
NaHCO3, 0.35 mg L-cysteine, and 20 U papain (Worthington), and in-
cubated at 37°C for 15 min. The suspension of DRG was centrifuged, and
the pellet was incubated in 1 ml Ca 2/Mg 2-free HBSS containing 4 mg
collagenase Type II and 1.25 mg dispase Type II (Worthington) at 37°C
for 15 min. After digestion, neurons were pelleted, resuspended in Neu-
robasal medium containing 2% B-27 supplement, 1% L-glutamine, 100
units/ml penicillin plus 100 g/ml streptomycin, and 50 ng/ml nerve
growth factor, plated on a 12 mm coverslip coated with poly-L-lysine
(10 g/ml), and cultured under a humidified atmosphere of 5% CO2/
95% air at 37°C for 18 –24 h before use.
Patch-clamp recording. Whole-cell patch-clamp recordings were per-
formed using an EPC 10 USB amplifier (HEKA Elektronik) at room
temperature (22°C-24°C) on the stage of an inverted phase-contrast mi-
croscope equipped with a filter set for green and red fluorescence visual-
ization. Pipettes pulled from borosilicate glass (BF 150-86-10; Sutter
Instruments) with a Sutter P-97 pipette puller had resistances of 2– 4 M
when filled with pipette solution containing the following (in mM): 140
CsCl, 1 EGTA, 1 MgCl2, and 10 HEPES, pH 7.4, and 315 mOsm/L. Cells
were continuously perfused with extracellular solution containing the
following (in mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, and 10
HEPES, pH adjusted to 7.4 with NaOH, and the osmolarity was adjusted
to340 mOsm/L with sucrose. The whole-cell membrane currents were
recorded using voltage ramp from100 to 100 mV for 500 ms at holding
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potential of 0 mV. For inside-out patch-clamp recordings, both the pi-
pette solution and bath solution contained the following (in mM): 140
CsCl, 1 EGTA, 1 MgCl2, 10 HEPES, pH 7.4. For current-clamp recording,
the pipette solution contained the following (in mM): 140 KCl, 1 MgCl2,
1 EGTA, 10 HEPES, and 5 ATP, pH 7.4, and 315 mOsm/L. Data were
acquired using PatchMaster software (HEKA Elektronik). Currents were
filtered at 2 kHz and digitized at 10 kHz. Data were analyzed and plotted
using Clampfit 10 (Molecular Devices). Values are given as mean	 SEM;
n indicates the number of measurements.
Calcium imaging. Cultured DRG neurons were loaded with 4 M
Fura-2 AM (Invitrogen) in culture medium at 37°C for 60 min. Cells
were then washed three times and incubated in HBSS at room tempera-
ture for 30 min before use. Fluorescence at 340 and 380 nm excitation
wavelengths was recorded on an inverted Nikon Ti-E microscope
equipped with 340 and 380 nm excitation filter wheels using NIS-
Elements imaging software (Nikon). Fura-2 ratios (F340/F380) were
used to reflect changes in intracellular Ca 2 upon stimulation. Values
were obtained from 100 to 250 cells in time-lapse images from each
coverslip. For FlexStation assays, HEK293 cells transfected with TRPV1
were plated in 96-well plate and maintained for 24–48 h before use. Cells
were loaded with Fluo-4 according to the man-
ufacturer’s protocol, washed again, and placed
on FlexStation 3 (Molecular Devices) to mea-
sure fluorescence increase upon addition of ag-
onist in the absence or presence of different
zinc compounds as described previously (Luo
et al., 2011).
Quantitative RT-PCR. Total RNA was ex-
tracted from mouse DRG using the RNeasy kit
(QIAGEN) according to the manufacturer’s
instructions. In brief, the mouse DRG were
collected and homogenized. A total of 1 g
RNA was treated with DNase I (Invitrogen),
and the cDNA was synthesized in vitro using
ThermoScript RT-PCR System kit (Invitrogen).
The real-time PCR was conducted following
the protocol for Fast SYBR Green Master Mix
kit (Applied Biosystems) in the StepOnePlus
Real-Time PCR System (Applied Biosystems)
with primers presented in Table 1. The expres-
sion levels of ZIPs were normalized to GAPDH
using the 2
CT method.
Nocifensive behavior. Each mouse was placed
individually in clear Plexiglas chambers (8 
8 12 cm) and acclimated for at least 1 h to the
testing environment before all experiments. To
measure pain-related behaviors, the left hind-
paws of mice were injected intraplantarly with
10 l vehicle (0.9% saline  5% DMSO 
0.5‰ Tween 80; Sigma-Aldrich) with or with-
out chemicals. The protocol for chemicals in-
jection was represented in Figures 1A, E, and
5B. Time spent on nocifensive behavior (flick-
ing and licking injected paw) was recorded for
5 min.
Experimental design and statistical analysis.
Both male and female mice were used in this
study. All data are presented as mean 	 SEM
for n independent observations. Statistical
analysis was performed using GraphPad Prism
5.0 software. Unpaired Student’s t test was used
to analyze statistical significance between two
groups (see Figs. 1E, 4A–D, 5E,H, and 6C).
One-way ANOVA was used where more than
two groups were compared (see Figs. 2C,D,
3B,C). Repeated-measures ANOVA was used
to compare differences between multiple
groups occurring over time (Figs. 1B–D, 5A,
and 6B). The post hoc Bonferroni test was per-
Figure 1. Zinc inhibits paclitaxel-inducedmechanical hypersensitivity in a TRPV1-dependentmanner.A, Schematic protocol of
induction of mechanical hypersensitivity by paclitaxel and administration of zinc. Paclitaxel (4 mg/kg) was administered through
intraperitoneal injections at days 0, 2, 4, and6. ZnAc (3, 10, or 30mM, 10l)was injected into theplantar of paclitaxel-treatedmice
at day7. Black arrows indicate thedateswhenvonFrey testswereperformed.B, Dose–dependent inhibitionof paclitaxel-induced
mechanical hypersensitivity by ZnAc. *p 0.05 versus saline group (repeated-measures ANOVA). **p 0.01 versus saline group
(repeated-measures ANOVA). ***p 0.001 versus saline group (repeated-measures ANOVA). n 5mice in each group. C, Time
courses show the hypersensitivity induced by paclitaxel in the contralateral paws of ZnAc- and saline-injectedmice. n 5mice in
each group.D, Time courses represent the effect of ZnAc on paclitaxel-inducedmechanical hypersensitivity in bothwild-type (n
7 mice) and TRPV1 KO (n 5 mice) mice. *p 0.05 versus wild-type group (repeated-measures ANOVA). **p 0.01 versus
wild-type group (repeated-measures ANOVA). E, Top, Schematic protocol of ZnAc inhibition of capsaicin-elicited acute nocifensive
responses. Bottom,Bar chart represents the inhibitionof ZnAcon capsaicin (0.5g, 10l)-inducedacutenociception. **p0.01
versus saline group (Student’s t test). n 7 mice for saline; and n 6 mice for ZnAc.
Table 1. Primer sequences used for themeasurement of ZIPs inmouse DRGwith
real time RT-PCRa
Name Forward (5¡ 3) Reverse (5¡ 3) Length (bp)
mZIP1 TGCTTGTGTCCTGGTCTTCTC ACAGGCTGACTGCCAGAATG 140
mZIP2 AGCCGCTGGCACGTTTTTATA ACCCAGCAGCCACACAGCTA 104
mZIP3 TGTCAGCTTCTCCTATGGCTTGT GGATCCCGCCTGCACTAATA 64
mZIP4 TCTGAGAAAGATGGGCCTTGTAG TGTTTGGACTGTCGGAGATTG 89
mZIP5 TCCAGTGGCCTCAGCACTA AGCAGCTTCCGAAAGGATAA 107
mZIP6 ACAGGGATATTCATCGGGCATTA AACCAGAGCGACATACATGAACAAG 90
mZIP7 TGCTGCCTGAGCTATTGAGAGA AATCAGTACCATCATGGCAACAC 92
mZIP8 AACAATTGCCTGGATGATCAC CAAAGTACAAGATGCCCCAATC 82
mZIP9 TAAGAGCAGTAAAGAAGCCCTTTCA ACGGTGGCAACATAAAGAAATC 90
mZIP10 GCCCTTCACCAGAGACCAATAA CCTCCTGACCTTCACTGACTTCA 65
mZIP11 CTCACCTGGGTGCTACAGAAGAC CAATGCAGGGTCCAAGTTCA 62
mZIP12 AATGTGCCAGCCTCCAACA TTACTAGGCCATCTGCAAAATTGTG 100
mZIP13 TGCTTGCCAACACCATAGACAAC CAGAAGCCCGATCTTTTTGC 83
mZIP14 TCTGCCAGGAGGATGAGAAG ATAATGGAGAAGCCGGTTAGG 85
mGAPDH AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 100
amZIP, Mouse zinc transporter of ZIP family; mGAPDH, mouse glyceraldehyde 3-phosphate dehydrogenase.
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formed following ANOVA analysis. A p value of 0.05 was considered
significantly different.
Results
Zinc inhibits paclitaxel-inducedmechanical hypersensitivity
in a TRPV1-dependent manner
Chemotherapy-induced neuropathic pain is a major dose-limiting
adverse effect in cancer chemotherapy, and lacks effective treat-
ments. Because zinc is used to soothe pain
and has shown promising effects in atten-
uating neuropathic pain caused by pe-
ripheral nerve injury (Liu et al., 1999;
Nozaki et al., 2011), we explored the pos-
sibility that zinc might attenuate pacli-
taxel-induced mechanical hypersensitivity
by applying ZnAc to the paw of paclitaxel-
treated mice through intraplantar injec-
tions. After four paclitaxel injections (Fig.
1A), mice developed mechanical allodynia,
which was markedly attenuated by admin-
istration of ZnAc in a dose-dependent man-
ner (F(3,96)  54.24, p  0.0001; Fig. 1B).
Moreover, the effect of ZnAc lasted for4 d
after a single injection (Fig. 1B). On the
other hand, ZnAc did not significantly in-
hibit paclitaxel-induced hypersensitivity of
contralateral paws (F(1,24)3.42,p0.101;
Fig. 1C), suggesting that ZnAc mainly exerts
the inhibitory effect locally. Previous studies
have demonstrated that enhanced expres-
sion and function of TRPV1 are tightly cor-
related with paclitaxel-induced mechanical
hypersensitivity, suggesting that targeting
TRPV1 for inhibition could be a novel ap-
proach for alleviating chemotherapy-induced
neuropathic pain (Anand et al., 2010; Chen
et al., 2011; Hara et al., 2013; Li et al., 2015;
Sisignano et al., 2016). We thus sought to
determine whether inhibition of paclitaxel-
induced mechanical hypersensitivity by zinc
is related to the inhibition of TRPV1 func-
tion. The data showed that the zinc-induced
sustained inhibitory effect was markedly
attenuated in TRPV1 KO mice compared
with wild-type mice (F(1,60)  9.56, p 
0.011; Fig. 1D). It should be noted that
TRPV1 deficiency did not abolish the
analgesic effect of zinc within the first
24 h after zinc administration, which
suggests that TRPV1-independent path-
ways are involved in the early phase of
zinc inhibition of paclitaxel-induced
neuropathic pain. These results suggest
that TRPV1 is critically involved in zinc-
induced analgesic effect in paclitaxel-
induced neuropathic pain. Furthermore,
when we applied ZnAc 20 min before in-
traplantar injections of capsaicin (Fig.
1E), the capsaicin-induced acute nocifen-
sive behaviors were also substantially re-
duced (t(14)  5.43, p  0.002; Fig. 1E).
Together, these results suggest that zinc
inhibits both acute and chronic pain sen-
sations mediated by TRPV1.
Extracellular zinc inhibits capsaicin response in
DRG neurons
To elucidate the cellular basis of the inhibitory effect of zinc on
TRPV1, we compared capsaicin-evoked [Ca 2]i response in cul-
tured mouse DRG neurons with and without pretreatment of
ZnCl2 (Sigma-Aldrich). Upon administration of extracellular
Figure2. Zinc inhibits capsaicin-induced [Ca 2]i response ina subset ofDRGneurons.A, Ratiometric Ca
2 imagingof cultured
wild-type mouse DRG neurons. Each trace corresponds to fluorescence in a single neuron. Neurons were exposed to 30M ZnCl2,
1M capsaicin, and 100mM KCl for the indicated times (colored bars). Red represents zinc-responsive neurons, which showed no
response to subsequent capsaicin application. Blue represents zinc-insensitive neurons, which responded to subsequent capsaicin
application. The remaining traces were recorded from the zinc- and capsaicin-insensitive cells. Right, Averaged responses of the
three subsets of DRG neurons. B, Ca 2 imaging of wild-type DRG neurons, exposed to 100M AITC, 1M capsaicin, and 100mM
KCl for the indicated times. Red represents AITC-responsive cells, which responded to subsequent capsaicin application. Blue
represents AITC-insensitive neurons, which also responded to subsequent capsaicin application. The remaining traces indicate the
AITC- and capsaicin-insensitive neurons. Right, Averaged responses of the three subsets of DRG neurons. C, Representative traces
and summarized data showing capsaicin-inducedmembrane depolarization and action potential firing before (left), during (mid-
dle), and after (right) the application of zinc in an untreatedwild-typemouse DRG neuron. Horizontal bars represent the indicated
time course of chemical applications. n.s., Not significant versus control group. *p 0.05 versus washout group (ANOVA). **p
0.01 versus control group (ANOVA). n 7 cells in each group.D, Representative traces and summarized data showing the effect of
ZnCl2 on capsaicin-induced membrane depolarization and action potential firing in a DiI-labeled DRG neuron from a paclitaxel-
treatedmouse. Inset, Representative picture of theDiI-labeledDRGneuron inwhich the voltage traces inDwere recorded. n.s., Not
significant versus control group. ***p 0.001 versus control and washout group (ANOVA). n 6 cells in each group.
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ZnCl2, three populations of neurons responded differentially to
subsequent applications of capsaicin: the first group of neurons
had no or negligible [Ca 2]i response to both ZnCl2 and capsai-
cin but had a large response to KCl (Fig. 2A, black traces); the
second group of neurons had no or negligible response to ZnCl2
but retained a large capsaicin response (Fig. 2A, blue traces); and
the third group of neurons had a large [Ca 2]i response to ZnCl2
but a negligible response to capsaicin (Fig. 2A, red traces). These
results indicate that neurons exhibiting large responses to ZnCl2
have severely attenuated capsaicin responses. Based on previous
studies showing that TRPA1 coexpresses with TRPV1 (Story et al.,
2003; Bautista et al., 2005) and TRPA1 mediates ZnCl2-elicited [Ca
2]i
response in DRG neurons (Andersson et al., 2009; Hu et al.,
2009), we speculated that activation of TRPA1 by ZnCl2 inhibits
TRPV1 function in the same DRG neurons. Unexpectedly, neurons
that responded to preapplied allyl isothiocyanate (AITC) (Fig. 2B,
red traces) still retained a large capsaicin-evoked [Ca 2]i response,
supporting reports that TRPA1 is expressed by a subset of
TRPV1-expressing nociceptors (Story et al., 2003; Jordt et al.,
2004), but activation of TRPA1 in general does not inhibit
TRPV1 function. Therefore, zinc-induced inhibition of TRPV1
in DRG neurons is a unique property of zinc, separable from
consequences resulting from activation of TRPA1 by other acti-
vators, such as AITC. We further examined the effect of zinc on
capsaicin-induced excitation of DRG neurons using current-
clamp recording. Consistent with Ca 2 imaging and behavioral
results, capsaicin evoked a large membrane potential depolariza-
tion and robust action potential firing, which was significantly
inhibited by pretreatment with extracellular ZnCl2 (F(2,18) 
8.81, p  0.002; Fig. 2C). To determine whether zinc could in-
hibit TRPV1-mediated excitation of DRG neurons specifically
innervating paws of paclitaxel-treated mice, we injected retro-
grade tracing dye DiI into the paws of paclitaxel-treated mice and
examined the effect of ZnCl2 on capsaicin-induced excitation of
the DiI-labeled DRG neurons. Indeed, ZnCl2 also severely re-
duced capsaicin-induced membrane depolarization of the la-
beled DRG neurons from mice treated with paclitaxel (F(2,15) 
22.20, p 0.0001; Fig. 2D), suggesting that zinc likely suppresses
TRPV1 function in DRG neurons innervating both skin and vis-
ceral organs (Vysotskaya et al., 2014). Moreover, ZnCl2 can in-
hibit TRPV1 function under normal conditions and in CIPN.
Zinc acts intracellularly to inhibit TRPV1
To further investigate the mechanism underlying zinc inhibition
of TRPV1, we tested the effect of ZnCl2 on TRPV1 heterologously
expressed in HEK293 cells. Unexpectedly, we did not detect an
inhibitory effect of ZnCl2 on capsaicin-induced [Ca
2]i response
and membrane current when ZnCl2 was applied extracellularly,
suggesting that extracellular zinc does not inhibit TRPV1 func-
tion and the lack of inhibition of extracellular ZnCl2 might be due
to the lack of entry route for zinc into the HEK293 cells. To test
this hypothesis, we used zinc pyrithione (ZnP), a zinc ionophore
that allows zinc entry into cells (Andersson et al., 2009). Indeed,
although pyrithione alone had no effect on the capsaicin-induced
[Ca 2]i response, ZnP exhibited a strong inhibition of capsaicin
response when applied to the extracellular site, suggesting that
zinc indeed acts intracellularly to inhibit TRPV1 function (F(2,15)
19.73, p 0.0001; Fig. 3A,B), which is consistent with a previous
report that zinc inhibited acid-evoked TRPV1 current intracellu-
Figure 3. Intracellular, but not extracellular, zinc inhibits capsaicin-induced responses. A, Representative traces showing [Ca 2]i responses induced by capsaicin in the presence of buffer (blue
circle), ZnCl2 (black circle), and ZnP (red circle) assayed by Flexstation.B, Bar graph represents the summarized data in A. **p 0.01 versus control group. n.s., Not significant versus control group
(ANOVA). n 6 for each condition. C, Bar graph represents capsaicin-activatedwhole-cell current densities at the holding potential of100mV in TRPV1-expressing HEK293 cells in the presence
of extracellular Pyr (30M), ZnCl2 (30M), and ZnP (30M). *p 0.05 versus control group. n.s., Not significant versus control group (ANOVA). n 5 cells in each group. D, Representative
current-voltage curves of capsaicin-activated membrane currents in response to voltage ramps from100 mV to100 mV (insert) in the absence (red) or presence (blue) of 100 nM zinc in the
recording pipette. E, Concentration-response curve for the inhibitory effect of intracellular zinc was fitted with the logistic equation: Y Ymin (Ymax Ymin)/(1 10
∧[(log EC50 X ) Hill
slope)], where Y is the response at a given concentration, Ymax and Ymin are the maximum andminimum response, X is the logarithmic value of the concentration, and Hill slope is the slope factor
of the curve. EC50 is the concentration that gives a response halfway between Ymax and Ymin. F, Representative traces show the capsaicin (500 nM)-activated macroscopic membrane currents from
an inside-out membrane patch at holding potentials of100 mV and100 mV; 100 nM zinc nearly abolished the capsaicin-activated current when applied to the inside of the membrane.
Horizontal bars represent the time course of chemical applications.
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larly in rat vagal bronchopulmonary sensory neurons (Vysots-
kaya et al., 2014). This conclusion is also supported by the
findings that capsaicin-activated whole-cell currents were severely re-
duced by application of extracellular ZnP but not pyrithione or
ZnCl2 (F(3,16)  6.05, p  0.006; Fig. 3C). To further test this
hypothesis, we applied ZnCl2 (with a final free Zn
2 concentra-
tion of 100 nM calculated using Maxchelatorprogram)directly to the
cytoplasmic side of TRPV1-expressing HEK293 cells by recording pi-
pette dialysis. Consistent with the ZnP result, intracellular ZnCl2
reduced capsaicin-activated whole-cell currents at both positive and
negative membrane potentials in a concentration-dependent
manner (Fig. 3D,E). The concentration-response curve of Zn 2
inhibition reveals an IC50 value of15 nM (Fig. 3E). In line with
these findings, when applied directly to the cytoplasmic side of
the membrane, zinc inhibited capsaicin-induced macroscopic cur-
rent in inside-out patches isolated from the TRPV1-expressing
HEK293 cells (Fig. 3F).
TPRA1mediates the inhibitory effect of extracellular zinc on
capsaicin-induced
nociception
The finding that zinc acts intracellularly to inhibit TRPV1 raises
the question about the route of zinc entry into DRG neurons. Our
previous studies have identified TRPA1 as a major route for zinc
entry into primary nociceptors because genetic ablation of TRPA1
function abolished the large zinc influx in
DRG neurons (Hu et al., 2009). In addition,
TRPA1 is selectively expressed by50% of
TRPV1-positive primary sensory nocicep-
tors (Story et al., 2003; Jordt et al., 2004;
Bautista et al., 2005). We thus asked
whether TRPA1 is required for inhibition
of TRPV1 in DRG neurons by extracellu-
lar zinc. To test this hypothesis, we first
examined the proportion of DRG neu-
rons responding to capsaicin in both wild-
type and TRPA1 KO mice in the presence
of extracellular ZnCl2. As shown in Figure
4A, deficiency of TRPA1 function signif-
icantly increased the proportion of
capsaicin-responsive DRG neurons in the
presence of extracellular ZnCl2 (t(8) 
3.52, p  0.023), suggesting that TRPA1
is involved in the inhibition of capsaicin
response by extracellular ZnCl2. Consis-
tent with this finding, zinc also exhib-
ited significantly less inhibitory effect
on capsaicin-evoked nocifensive response
in the TRPA1 KO mice compared with the
wild-type mice (t(11)  4.003, p  0.002;
Fig. 4B).
To further elucidate the role of TRPA1
in extracellular zinc-induced inhibition of
TRPV1, we examined ZnCl2-induced inhi-
bition of capsaicin response in HEK293
cells coexpressing TRPV1 and TRPA1. In
marked contrast to the finding that capsa-
icin response in HEK293 cells expressing
TRPV1 alone was not inhibited by ex-
tracellular ZnCl2 (Fig. 3C), capsaicin-
induced current was substantially inhibited
by extracellular ZnCl2 in HEK293 cells
cotransfected with TRPV1 and TRPA1
constructs (t(10)  3.11, p  0.023; Fig. 4C), suggesting that
TRPA1 can indeed serve as an important zinc carrier mediating
zinc influx for inhibition of TRPV1 function in the same cell. We
further investigated whether zinc permeation mutation of
TRPA1 affects the inhibitory effect of zinc on capsaicin response
by coexpressing TRPV1 and mutant TRPA1-D915A, which is
functional but lacks zinc permeability (Hu et al., 2009). As ex-
pected, capsaicin-induced current was not significantly inhibited
by extracellular zinc in HEK293 cells expressing TRPV1 and mu-
tant TRPA1-D915A (t(10)  1.366, p  0.199; Fig. 4D). Com-
bined, these results demonstrate that TRPA1 serves as a cellular
zinc entry route for the zinc inhibition of TRPV1function.
Inhibition of paclitaxel-induced chronic neuropathic pain by
zinc requires zinc transporters but not TRPA1
Next, we tested whether TRPA1 is also required for zinc inhibi-
tion of paclitaxel-induced chronic neuropathic pain. To our sur-
prise, the inhibitory effect of zinc on mechanical hypersensitivity
induced by paclitaxel was not significantly different between
TRPA1 KO mice and wild-type mice (F(1,60)  0.01, p  0.971;
Fig. 5A), suggesting that TRPA1 is not a primary carrier of zinc
entry into primary nociceptors to inhibit TRPV1-dependent chronic
neuropathic pain induced by paclitaxel. TRPA1 is a highly desensi-
tizing channel, especially in the presence of physiological concentra-
tions of extracellular Ca 2 (1–3 mM) (Akopian et al., 2007). The
Figure 4. TRPA1 is required for the inhibitory effect of zinc on TRPV1-mediated acute responses. A, Bar graph represents the
percentages of wild-type and TRPA1 KO DRG neurons responding to capsaicin in the presence of extracellular zinc (30M). *p
0.05 versus wild-type group (Student’s t test). n 5 coverslips in each group.B, Bar graph represents the effects of pretreatment
with zinc (30mM, 10l) on capsaicin (0.5g, 10l)-induced nociceptive behaviors inwild-type and TRPA1 KOmice. **p 0.01
versuswild-type group (Student’s t test). n 7mice for thewild-type group and n 6mice for the TRPA1 KO group. C, Capsaicin
(1 M)-activated inward currents in the presence of normal extracellular buffer (ECS, left) or ECS plus zinc (30 M, middle) in
HEK293 cells coexpressing TRPV1 and wild-type TRPA1. Right, Summarized data. *p 0.05 versus ECS group (Student’s t test).
n 6 cells in each group. D, Capsaicin (1M)-activated inward currents in the presence of ECS (left) or ECS plus zinc (30M,
middle) in HEK293 cells coexpressing TRPV1 and the TRPA1 zinc permeation mutant (D915). The summarized data are shown on
the right. n.s., Not significant versus ECS group (Student’s t test). n 6 cells in each group.
Luo et al. • Zinc Inhibits Paclitaxel-Induced Pain J. Neurosci., January 10, 2018 • 38(2):474–483 • 479
fact that TRPA1 is involved in the zinc inhibition of capsaicin-
induced acute nociception, but not paclitaxel-induced TRPV1-
dependent chronic neuropathic pain, raises the possibility that
TRPA1 might desensitize over time following initial activation in
the presence of sustained high levels of extracellular zinc, making
it unavailable for zinc influx. To test this hypothesis, we examined
the effect of zinc on AITC-induced nocifensive behaviors. Con-
sistent with our previous study (Hu et al., 2009), intraplantar
injections of ZnAc elicited robust nocifensive behaviors lasting
for15 min. However, subsequent application of AITC failed to
evoke obvious nocifensive behaviors, which is in marked contrast
to the robust nociceptive responses induced by AITC in the ab-
sence of zinc (t(8) 3.186, p 0.013; Fig. 5B–E). Similarly, AITC-
induced membrane current in TRPA1-expresing HEK293 cells was
also greatly attenuated by the preapplied zinc, which initially acti-
vated a large membrane current (t(9)3.716,p0.005; Fig. 5F–H).
These results support that zinc-elicited TRPA1 desensitization might
account for the ineffectiveness of TRPA1 in mediating zinc inhi-
bition of TRPV1 in the chronic neuropathic pain induced by
paclitaxel.
In addition to TRPA1, ZIPs also serve as important entry
pathways for extracellular zinc in mammalian cells (Cousins et
al., 2006; Kambe et al., 2015). We thus determined the expression
of ZIPs in mouse DRG using quantitative RT-PCR. Among 14
known ZIPs, ZIP3, ZIP6, and ZIP7 were the most abundant iso-
forms in mouse DRG (Fig. 6A). We therefore knocked down the
expression of these three ZIPs through intrathecal administration
of siRNAs and then examined the inhibitory effect of zinc on
paclitaxel-induced mechanical hypersensitivity. Strikingly, zinc-
induced inhibitory effect on paclitaxel-induced mechanical hyper-
sensitivity was significantly reduced in mice treated with siRNAs
against ZIP3, ZIP6, and ZIP7 compared with mice treated with non-
targeting control siRNA only (F(1,48) 45.20, p 0.0001; Fig. 6B),
suggesting that these three ZIPs are significantly involved in zinc
inhibition of paclitaxel-induced chronic neuropathic pain. Con-
sistent with behavioral studies, the inhibitory effect of zinc on
Figure 5. TRPA1 is not involved in zinc inhibition of paclitaxel-induced mechanical hypersensitivity, and zinc strongly desensitizes TRPA1-mediated current and acute nocifensive responses.
A, Intraplantar injection of ZnAc (30 mM, 10l) produced a similar inhibition on paclitaxel-induced mechanical hypersensitivity in both wild-type and TRPA1 KO mice. n 6 mice in each group.
B, Schematic protocol of zinc-induced inhibition of AITC (75mM, 10l)-elicited acute nocifensive responses. Animals were acclimated for 1 h before ZnAc (30mM) or saline administration into the
paws. Twentyminutes later, AITC (75mM, 10l) was injected into the same paws. The nocifensive responseswere recorded for 5min after AITC administration. C, Bar graph demonstrates that AITC
elicited a robust nocifensive response inmicepretreatedwith saline.D, Intraplantar injections of ZnAc (30mM, 10l) producedanocifensive response that gradually desensitizedwithin 20minafter
administration. Subsequent applications of AITC (75mM, 10l) did not evokemeasurable nocifensive responses. E, Bar chart represents AITC (75mM, 10l)-elicited nocifensive responses inmice
20min after pretreatmentwith either 10l saline or ZnAc (30mM). *p 0.05 versus saline group (Student’s t test). n 5mice in each group. F–H, Extracellular application of zinc (30M) (G), but
not ECS (F ), nearly abolishedmembrane current activated by subsequent application of AITC (100M) in TRPA1-expressing HEK293 cells.H, Summarized data from F andG. **p 0.01 versus ECS
group (Student’s t test). n 6 for ECS and n 5 for ZnCl2.
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capsaicin-induced membrane depolarization was also signifi-
cantly attenuated in DRG neurons isolated from mice treated
with siRNAs against selected three ZIPs compared with those
from mice treated with nontargeting control siRNA (t(12) 
3.066, p 0.012; Fig. 6C). These data strongly support that ZIP3,
ZIP6, and ZIP7, but not TRPA1, are required for zinc-induced
inhibition on chronic neuropathic pain produced by paclitaxel
treatment.
Discussion
CIPN is a common consequence of chemotherapy that is neither
well understood nor effectively treated. It affects50% of cancer
patients treated with commonly used classes of chemotherapy
drugs, and has a significant negative impact on treatment out-
come and patient’s quality of life. Therefore, effective and safe
treatment strategies are urgently needed to reduce the often per-
sistent and debilitating effects of painful CIPN. In this study, we
have provided evidence that locally injected zinc is effective in reduc-
ing mechanical hypersensitivity induced by paclitaxel treatment in a
TRPV1-dependent manner, having little effect on the contralateral
paws. We further show that extracellular zinc is a potent inhibitor of
TRPV1 expressed in DRG neurons both under normal conditions
and in CIPN and suppresses capsaicin-elicited acute nocifensive re-
sponses. Zinc-induced inhibition of TRPV1 function requires the
presence of TRPA1 that facilitates zinc influx, and genetic ablation of
TRPA1 function severely reduces the inhibitory effect of zinc on
capsaicin responses both in vitro and in vivo. Unexpectedly, we show
that inhibition of paclitaxel-induced neuropathic pain by zinc is not
mediated by TRPA1, which might result from the desensitization
property of the channel. Instead, zinc trans-
porters, especially ZIP3, ZIP6, and ZIP7, are
critically involved in the zinc inhibition of
mechanical hypersensitivity induced by
paclitaxel treatment. Our results suggest
that zinc suppresses both acute nociception
and chemotherapy-induced chronic neuro-
pathic pain through inhibiting TRPV1,
although distinct zinc entry routes are re-
quired under acute and chronic settings.
Zinc has been widely used as an anti-
inflammatory and antiarthritic agent
(Cousins and Swerdel, 1985; Whitehouse
et al., 1990). Several lines of evidence sug-
gest that exogenously applied zinc has an
antihyperalgesic effect in a number of in-
flammatory and neuropathic pain model
systems (Safieh-Garabedian et al., 1996;
Larson and Kitto, 1999; Liu et al., 1999;
Nozaki et al., 2011). Although the mecha-
nisms underlying zinc modulation of pain
responses are complex, zinc has been
shown to regulate functions of many
pain-related ion channels, including acid-
sensing ion channels (Jiang et al., 2011),
TRPV1 (Vysotskaya et al., 2014), and
NMDA receptors (Nozaki et al., 2011;
Peralta and Huidobro-Toro, 2016). We
and others have previously shown that
zinc activates and permeates the pain-
initiating TRPA1 channels and elicits a
nociceptive response (Andersson et al.,
2009; Hu et al., 2009; Vysotskaya et al.,
2014). Nevertheless, in the present study,
we showed that zinc inhibits TRPV1 and
suppresses capsaicin-induced excitation of DRG neurons and
nociceptive responses, which requires the expression of TRPA1.
Several lines of evidence have demonstrated mutual modulation
between TRPV1 and TRPA1, which are coexpressed in primary
nociceptors (Staruschenko et al., 2010; Spahn et al., 2014; Weng et
al., 2015). However, TRPA1 agonist AITC did not inhibit capsaicin
responses, suggesting that the inhibitory effect of zinc on TRPV1
is an intrinsic property of zinc, separable from other TRPA1 ac-
tivators. This is further confirmed by the finding that zinc per-
meation mutation of TRPA1 abolished the inhibitory effect of
zinc on TRPV1. These data indicate that TRPA1 serves as the
entry route for extracellular zinc to gain access to the intracellular
side of the cell and suppress TRPV1. Furthermore, zinc applica-
tion markedly desensitizes TRPA1-mediated membrane currents
in heterologous cells and AITC-elicited nocifensive responses in
vivo. These findings might provide distinct mechanisms under-
lying the antihyperalgesic effect of zinc through inhibition of
both TRPA1 and TRPV1.
AlthoughtheroleofTRPV1inthepathogenesisofchemotherapy-
induced chronic neuropathic pain is still largely unknown, accu-
mulating evidence suggests that both expression and function of
TRPV1 are increased upon treatment with commonly used che-
motherapy drugs. For instance, TRPV1 expression in both skin
and DRG is increased in rats treated with paclitaxel (Hara et al.,
2013). Consistent with enhanced expression, treatment with ox-
aliplatin increases intracellular cAMP and sensitizes responses
elicited by capsaicin and icilin in DRG neurons (Anand et al.,
2010). Importantly, many exogenous and endogenous TRPV1
Figure6. Inhibition of paclitaxel-inducedmechanical hypersensitivity by zinc requires ZIPs.A, Relative expression of 14 ZIP zinc
transporters in mouse DRG. The most abundantly expressed three ZIPs are highlighted in red. B, Intrathecal application of siRNAs
against ZIP3, ZIP6, and ZIP7, but not control siRNA, severely reduced the inhibitory effect of ZnAc onpaclitaxel-inducedmechanical
hypersensitivity. *p 0.05 versus control siRNA group (repeated-measures ANOVA). **p 0.01 versus control siRNA group
(repeated-measures ANOVA).n5mice for eachgroup.C, Bar chart demonstrates that inhibition of capsaicin-evokedmembrane
depolarization by zinc in DRG neurons was significantly attenuated by intrathecally applied siRNAs against ZIP3, ZIP6, and ZIP7
comparedwith that inDRGneurons treatedwith control siRNA. *p0.05 versus control siRNAgroup (Student’s t test).n7 cells
for each group.
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inhibitors efficiently reduce chemotherapy-induced neuropathic
pain through either direct inhibition of TRPV1 or indirect inhi-
bition of TRPV1 sensitization by signal transduction metabolites
(Sałat et al., 2014; Gao et al., 2016; Sisignano et al., 2016). Inter-
estingly, although TRPV1 antagonists have been shown to reduce
neuropathic pain (Chen et al., 2011; Li et al., 2015), we found that
the mechanical hypersensitivity in wild-type mice was not signif-
icantly different from the TRPV1 KO mice when both were
treated with paclitaxel, suggesting that there might be a genetic
redundancy for paclitaxel-induced pain response in mice.
On the other hand, exogenously applied zinc markedly re-
duced mechanical hypersensitivity produced by paclitaxel treat-
ment in a TRPV1-dependent manner. Unexpectedly, although
the inhibitory effect of zinc on capsaicin-induced response was
completely abolished by the absence of TRPA1 or in the presence
of the zinc permeation mutation of TRPA1 in heterologous cells,
zinc still exhibited inhibitory effect on paclitaxel-induced neuro-
pathic pain in TRPA1 KO mice, indicating that TRPA1 function
is not essential or unavailable for the zinc entry under chronic
settings. These data are consistent with the findings that zinc
desensitizes TRPA1 function both in vitro and in vivo, and suggest
that alternative zinc entry routes may also exist in DRG neurons
in vivo, such as a large number of zinc transporters, which could
mediate the influx of zinc into nociceptors (Cousins et al., 2006).
Indeed, we detected abundant expression of ZIP3, ZIP6, and
ZIP7 in DRG, and administration of siRNAs against these three
ZIPs markedly reduced the inhibitory effect of zinc on paclitaxel-
induced mechanical hypersensitivity. Our results suggest that
ZIPs are critically involved in zinc entry into nociceptors, which
leads to inhibition of TRPV1-dependent neuropathic pain pro-
duced by paclitaxel treatment.
Although TRPV1 is also reported to express centrally in the
thalamus, locus ceruleus, periaqueductal gray, cortex, and spinal
cord (Steenland et al., 2006; Kim et al., 2012), recent studies using
TRPV1 reporter mice have shown that TRPV1 is primarily ex-
pressed by primary nociceptors with minimal expression in the
CNS that is restricted to the area around the caudal hypothala-
mus (Cavanaugh et al., 2011a, b). Our study demonstrates that
zinc inhibits TRPV1-dependent acute and chronic pain responses in
primary nociceptors, revealing a novel peripheral mechanism for
zinc-mediated analgesic effect. Locally injected zinc could produce a
sustained inhibition of TRPV1 and reduce chemotherapy-induced
neuropathic pain for4 d after one single injection. Interestingly,
CIPN generally develops with a symmetric, distal, and length-
dependent “glove and stocking” distribution affecting predomi-
nantly the feet and hands at the extremities. Thus, administration
of zinc to localized areas associated with pain might be an effec-
tive and safe approach to treat pain without causing systemic side
effects, considering that zinc plays a critical role in regulating
neurotransmissions in the CNS (Jo et al., 2000; Smart et al., 2004;
Wall, 2005; Nakashima and Dyck, 2009; Marger et al., 2014).
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